In breast cancer, it has been demonstrated that pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating Foxp3+ regulatory T cells [65]. This evidence concerns the gene FOXP3 and breast carcinoma.